Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Sep 12, 2007 by Edgar Snyder

New Study Confirms Avandia Dangers

Avandia

Study results affirming the dangers of Avandia have been released just less than one month from the date the diabetes drug received a black box warning label from the Food and Drug Administration (FDA). In the study, researchers found that patients taking Avandia had a 42 percent greater chance of having a heart attack than patients taking other medication or a placebo.

Published by the Journal of the American Medical Association, the study analyzed over 14,000 patients. Of the 6,421 taking Avandia, 94 patients suffered heart attacks. These findings were in line with a study released in May of this year that prompted the FDA to take a closer look at Avandia’s risk of heart attack.

Another study was released in the same publication that showed more promising results for Avandia’s only competitor, Actos. Researchers found that patients taking Actos were 18 percent less likely to suffer a heart attack than patients on other drugs or a placebo. Results were compiled and analyzed from 19 previous clinical trials of Actos.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Maryland, Ohio, and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "Glaxo Diabetes Drug Is Dealt Fresh Blows." By Jeanne Whalen. Wall Street Journal. September 12, 2007.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Tweet